文献速递产科

氯己定与聚维酮碘阴道准备的杀菌效果随机试验

A randomized trial of the bactericidal effects of chlorhexidine vs povidone-iodine vaginal preparation.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-04-15

该前瞻性随机对照试验在≥34周剖宫产孕妇中比较0.5%氯己定葡萄糖酸盐、10%聚维酮碘与生理盐水阴道准备的杀菌效果。共29例孕妇纳入,聚维酮碘组需氧和厌氧菌落数低于氯己定组和盐水组(P≤.01和P≤.0001),聚维酮碘消除超过99.9%细菌,而氯己定和盐水分别消除超过99%和95%。

要点

  • 10%聚维酮碘阴道准备降低剖宫产前阴道细菌菌落数优于0.5%氯己定。
  • 聚维酮碘消除超过99.9%细菌,氯己定超过99%,盐水超过95%。
  • 0.5%氯己定减少厌氧菌效果不优于生理盐水。

核心结论

  • 与0.5%氯己定葡萄糖酸盐相比,10%聚维酮碘在剖宫产前更有效地降低阴道细菌菌落数。

研究设计与样本

  • 前瞻性随机对照试验,纳入29例≥34周妊娠行剖宫产的孕妇,随机接受0.5%氯己定葡萄糖酸盐(n=10)、10%聚维酮碘(n=9)或生理盐水(n=10)阴道准备。

主要发现

  • 聚维酮碘组需氧和厌氧菌落数低于氯己定组和盐水组(P≤.01和P≤.0001)。
  • 聚维酮碘消除超过99.9%细菌,氯己定消除超过99%,盐水消除超过95%。
  • 0.5%氯己定减少厌氧菌效果不优于生理盐水。
  • 各组基线菌落数无差异,未报告不良事件或产后感染。

关键数值与推荐

  • 主要结局为干预后需氧和厌氧细菌菌落数,由盲法研究者评估。
  • 阴道标本在手术室于阴道清洗前和清洗后5-10分钟无菌采集。

临床怎么用

  • 对于≥34周剖宫产孕妇,10%聚维酮碘阴道准备可能比0.5%氯己定更有效降低阴道细菌负荷。

局限性

  • 样本量小(共29例),各组仅9-10例。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Precesarean vaginal preparation significantly reduces postpartum infections. Although povidone-iodine is the most commonly used vaginal antiseptic, evidence suggests that chlorhexidine gluconate may be more effective. OBJECTIVE: We aimed to compare the bactericidal effect of chlorhexidine gluconate and povidone-iodine on vaginal bacterial colony counts in pregnancy. MATERIALS AND METHODS: We conducted a prospective randomized controlled trial of vaginal preparation with 0.5% chlorhexidine gluconate vs 10% povidone-iodine vs saline in women undergoing cesarean delivery at ≥34 weeks' gestation. Women in labor or those with ruptured membranes, chorioamnionitis, abnormal placentation, or allergy to study agents were excluded. Vaginal specimens were collected aseptically in the operating room immediately before and 5-10 minutes after vaginal cleansing with 3 sterile sponge sticks. Our primary outcome was postintervention aerobic and anaerobic bacterial colony counts, assessed by blinded investigators. Two-way analysis of variance with simple-effects analysis and Tukey post hoc test were used for multiple group comparisons. Secondary outcomes included baseline colony counts, change in colony counts, adverse events, and maternal infections. RESULTS: A total of 29 women consented and underwent vaginal preparation with chlorhexidine gluconate (n=10), povidone-iodine (n=9), or saline (n=10). Groups were similar with respect to maternal age, body mass index, race, ethnicity, parity, group B streptococcus status, and gestational age. There were no differences in baseline colony counts. Vaginal preparation with povidone-iodine resulted in lower aerobic and anaerobic colony counts compared with chlorhexidine gluconate and saline (P≤.01 and P≤.0001, respectively). Povidone-iodine eliminated more than 99.9% of bacteria, whereas chlorhexidine gluconate and saline eliminated more than 99% and 95% of bacteria, respectively. Although all agents decreased aerobic and anaerobic bacterial counts, 0.5% chlorhexidine gluconate was no more effective than saline in reducing anaerobic bacteria. There were no reported adverse effects or postpartum infections. CONCLUSION: Compared with 0.5% chlorhexidine gluconate, 10% povidone-iodine was more effective in reducing vaginal bacterial colony counts before cesarean delivery.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Duffy CR, Garcia-So J, Ajemian B, et al. A randomized trial of the bactericidal effects of chlorhexidine vs povidone-iodine vaginal preparation. Am J Obstet Gynecol MFM. 2020. PMID: 33345865. doi:10.1016/j.ajogmf.2020.100114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。